Laboratories advised to look out for tuberculosis false-positives
This article was originally published in Clinica
Tuberculosis control programmes should always be on the lookout for clusters of false-positive diagnoses in the data they analyse, advises the US Centers for Disease Control. The CDC's Mortality and Morbidity Weekly Report on August 29 analyses a series of five incidents in which 11 patients were misdiagnosed as having TB.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.